Concepts (131)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Prostatic Neoplasms | 6 | 2021 | 37 | 1.150 |
Why?
|
| Surgical Procedures, Operative | 2 | 2017 | 6 | 0.990 |
Why?
|
| Health Education | 3 | 2016 | 18 | 0.910 |
Why?
|
| Early Detection of Cancer | 4 | 2016 | 32 | 0.810 |
Why?
|
| African Americans | 4 | 2016 | 272 | 0.690 |
Why?
|
| Physicians | 2 | 2017 | 16 | 0.660 |
Why?
|
| Hospitals, Community | 1 | 2017 | 2 | 0.640 |
Why?
|
| Decision Support Techniques | 2 | 2021 | 13 | 0.640 |
Why?
|
| Safety-net Providers | 1 | 2017 | 17 | 0.630 |
Why?
|
| Humans | 19 | 2021 | 2493 | 0.600 |
Why?
|
| Aged | 9 | 2016 | 607 | 0.410 |
Why?
|
| Homeless Persons | 1 | 2010 | 20 | 0.390 |
Why?
|
| Wounds and Injuries | 1 | 2010 | 15 | 0.390 |
Why?
|
| Social Class | 1 | 2010 | 25 | 0.380 |
Why?
|
| Health Status | 1 | 2010 | 39 | 0.380 |
Why?
|
| Male | 12 | 2021 | 1649 | 0.380 |
Why?
|
| Retrospective Studies | 7 | 2017 | 210 | 0.370 |
Why?
|
| Health Facility Size | 1 | 2009 | 1 | 0.350 |
Why?
|
| Regional Health Planning | 1 | 2009 | 1 | 0.350 |
Why?
|
| Certification | 1 | 2009 | 2 | 0.350 |
Why?
|
| Academic Medical Centers | 2 | 2021 | 6 | 0.350 |
Why?
|
| Barbering | 3 | 2016 | 4 | 0.340 |
Why?
|
| Health Promotion | 3 | 2016 | 31 | 0.330 |
Why?
|
| Middle Aged | 7 | 2016 | 799 | 0.310 |
Why?
|
| Insurance, Pharmaceutical Services | 1 | 2006 | 1 | 0.300 |
Why?
|
| Health Services for the Aged | 1 | 2006 | 5 | 0.300 |
Why?
|
| Health Policy | 1 | 2006 | 3 | 0.300 |
Why?
|
| Drug Prescriptions | 1 | 2006 | 6 | 0.300 |
Why?
|
| Medicare | 1 | 2006 | 19 | 0.290 |
Why?
|
| Prostate-Specific Antigen | 4 | 2013 | 6 | 0.280 |
Why?
|
| Adult | 4 | 2016 | 807 | 0.250 |
Why?
|
| Mathematics | 1 | 2003 | 1 | 0.230 |
Why?
|
| Body Weight | 1 | 2003 | 65 | 0.230 |
Why?
|
| Healthcare Disparities | 3 | 2017 | 27 | 0.210 |
Why?
|
| Decision Making | 2 | 2021 | 11 | 0.200 |
Why?
|
| Mass Screening | 2 | 2012 | 66 | 0.200 |
Why?
|
| Delivery of Health Care | 2 | 2017 | 39 | 0.180 |
Why?
|
| Child | 3 | 2011 | 126 | 0.180 |
Why?
|
| Ambulatory Surgical Procedures | 1 | 2017 | 5 | 0.160 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2017 | 14 | 0.160 |
Why?
|
| Los Angeles | 1 | 2017 | 210 | 0.150 |
Why?
|
| Uncertainty | 1 | 2016 | 2 | 0.150 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2016 | 64 | 0.140 |
Why?
|
| Female | 5 | 2013 | 1733 | 0.130 |
Why?
|
| Infant | 2 | 2011 | 52 | 0.120 |
Why?
|
| Child, Preschool | 2 | 2011 | 64 | 0.120 |
Why?
|
| Hospitalization | 2 | 2011 | 40 | 0.120 |
Why?
|
| Amputation | 1 | 2013 | 1 | 0.120 |
Why?
|
| Vascular Surgical Procedures | 1 | 2013 | 1 | 0.120 |
Why?
|
| Lower Extremity | 1 | 2013 | 1 | 0.120 |
Why?
|
| Ischemia | 1 | 2013 | 3 | 0.120 |
Why?
|
| Young Adult | 2 | 2011 | 175 | 0.120 |
Why?
|
| Risk Factors | 2 | 2011 | 240 | 0.120 |
Why?
|
| Adolescent | 2 | 2011 | 305 | 0.120 |
Why?
|
| Prostate | 1 | 2013 | 10 | 0.120 |
Why?
|
| Managed Care Programs | 1 | 2013 | 6 | 0.120 |
Why?
|
| United States | 3 | 2010 | 324 | 0.110 |
Why?
|
| Severity of Illness Index | 1 | 2011 | 27 | 0.110 |
Why?
|
| Fractures, Bone | 1 | 2011 | 14 | 0.110 |
Why?
|
| Budgets | 1 | 2011 | 2 | 0.100 |
Why?
|
| New York City | 1 | 2010 | 7 | 0.100 |
Why?
|
| Residence Characteristics | 1 | 2010 | 19 | 0.100 |
Why?
|
| Community Networks | 1 | 2010 | 4 | 0.100 |
Why?
|
| California | 3 | 2017 | 93 | 0.090 |
Why?
|
| Thoracic Surgery | 1 | 2009 | 1 | 0.090 |
Why?
|
| General Surgery | 1 | 2009 | 3 | 0.090 |
Why?
|
| Hospitals, Veterans | 1 | 2009 | 4 | 0.090 |
Why?
|
| Medical Records | 1 | 2009 | 18 | 0.090 |
Why?
|
| Social Support | 1 | 2010 | 26 | 0.090 |
Why?
|
| Data Collection | 1 | 2009 | 20 | 0.090 |
Why?
|
| Quality Assurance, Health Care | 1 | 2009 | 13 | 0.090 |
Why?
|
| Cardiovascular Diseases | 1 | 2010 | 36 | 0.090 |
Why?
|
| Social Change | 1 | 2006 | 3 | 0.070 |
Why?
|
| Cost Savings | 1 | 2006 | 6 | 0.070 |
Why?
|
| Medicaid | 1 | 2006 | 7 | 0.070 |
Why?
|
| Insurance Coverage | 1 | 2006 | 9 | 0.070 |
Why?
|
| Papilloma | 1 | 2004 | 1 | 0.070 |
Why?
|
| Calorimetry | 1 | 2003 | 1 | 0.060 |
Why?
|
| Weight Loss | 1 | 2003 | 17 | 0.060 |
Why?
|
| Curriculum | 1 | 2003 | 15 | 0.060 |
Why?
|
| Glomerular Mesangium | 1 | 2002 | 1 | 0.060 |
Why?
|
| Oxidants | 1 | 2002 | 2 | 0.060 |
Why?
|
| Glucose | 1 | 2002 | 39 | 0.060 |
Why?
|
| Incidence | 2 | 2013 | 55 | 0.050 |
Why?
|
| Follow-Up Studies | 2 | 2013 | 95 | 0.050 |
Why?
|
| Breast Neoplasms | 1 | 2004 | 167 | 0.050 |
Why?
|
| Age Factors | 2 | 2012 | 90 | 0.050 |
Why?
|
| Reference Values | 2 | 2011 | 42 | 0.050 |
Why?
|
| Sensitivity and Specificity | 2 | 2011 | 45 | 0.050 |
Why?
|
| Aged, 80 and over | 2 | 2013 | 246 | 0.050 |
Why?
|
| Patient Participation | 1 | 2021 | 10 | 0.050 |
Why?
|
| Apoptosis | 1 | 2002 | 162 | 0.050 |
Why?
|
| Logistic Models | 1 | 2013 | 64 | 0.030 |
Why?
|
| Area Under Curve | 1 | 2013 | 7 | 0.030 |
Why?
|
| Neoplasm Grading | 1 | 2013 | 5 | 0.030 |
Why?
|
| ROC Curve | 1 | 2013 | 12 | 0.030 |
Why?
|
| Biopsy | 1 | 2013 | 16 | 0.030 |
Why?
|
| Prognosis | 1 | 2013 | 47 | 0.030 |
Why?
|
| Biomarkers, Tumor | 1 | 2013 | 32 | 0.030 |
Why?
|
| Markov Chains | 1 | 2011 | 1 | 0.030 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2011 | 1 | 0.030 |
Why?
|
| New York | 1 | 2011 | 3 | 0.030 |
Why?
|
| Cost-Benefit Analysis | 1 | 2011 | 17 | 0.030 |
Why?
|
| Age Distribution | 1 | 2011 | 18 | 0.030 |
Why?
|
| Infant, Newborn | 1 | 2011 | 49 | 0.030 |
Why?
|
| Models, Economic | 1 | 2011 | 1 | 0.030 |
Why?
|
| Probability | 1 | 2011 | 16 | 0.030 |
Why?
|
| Prevalence | 1 | 2011 | 114 | 0.030 |
Why?
|
| Computer Simulation | 1 | 2011 | 16 | 0.030 |
Why?
|
| Program Development | 1 | 2010 | 15 | 0.020 |
Why?
|
| Benchmarking | 1 | 2009 | 1 | 0.020 |
Why?
|
| Policy Making | 1 | 2009 | 2 | 0.020 |
Why?
|
| Medical Audit | 1 | 2009 | 11 | 0.020 |
Why?
|
| Program Evaluation | 1 | 2009 | 16 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2009 | 52 | 0.020 |
Why?
|
| Radiography | 1 | 2004 | 9 | 0.020 |
Why?
|
| Biopsy, Needle | 1 | 2004 | 12 | 0.020 |
Why?
|
| Cytochrome c Group | 1 | 2002 | 3 | 0.010 |
Why?
|
| Subcellular Fractions | 1 | 2002 | 6 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2002 | 7 | 0.010 |
Why?
|
| Immunoblotting | 1 | 2002 | 12 | 0.010 |
Why?
|
| Cell Survival | 1 | 2002 | 17 | 0.010 |
Why?
|
| Caspases | 1 | 2002 | 21 | 0.010 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2002 | 15 | 0.010 |
Why?
|
| Reactive Oxygen Species | 1 | 2002 | 36 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2002 | 24 | 0.010 |
Why?
|
| Cell Line | 1 | 2002 | 80 | 0.010 |
Why?
|
| NF-kappa B | 1 | 2002 | 26 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2002 | 118 | 0.010 |
Why?
|
| Mice | 1 | 2002 | 508 | 0.010 |
Why?
|
| Animals | 1 | 2002 | 1238 | 0.010 |
Why?
|